AI Swarms Autonomously Discover Cancer Vulnerabilities with Clinical Translation

The process of automated scientific discovery has been hampered by the disconnect between the semantic reasoning capabilities of large language models (LLMs) and the precise, deterministic physics governing biological systems. While multi-agent AI frameworks have shown promise in generating hypotheses and analyzing in vitro experiments, they often lack the rigorous, causal constraints necessary for translating findings into clinical applications across multiple scales. Additionally, existing algorithmic clinical digital twins, though effective at forecasting biological states, frequently rely on opaque "black-box" models, sacrificing interpretability for predictive power. Researchers have introduced the Multi-Scale Autonomous Discovery Engine, named Octopus, a neuro-symbolic architecture designed to bridge this gap. Octopus integrates zero-leakage, local LLM swarms with strict algorithmic physics engines. This system autonomously generates therapeutic hypotheses by analyzing in vitro CRISPR dependency data, traces dynamic causal pathways using mechanistic interpretability tools, and then translates these emergent vulnerabilities in silico to predict real-world mammalian tumor trajectories and human overall survival. In an unsupervised analysis of colorectal cancer transcriptomes, Octopus autonomously identified Insulin-like Growth Factor 2 (IGF2) as a critical vulnerability to 5-Fluorouracil resistance, a discovery validated with statistical significance in both in vivo mouse models and human survival data. This framework establishes a verifiable, end-to-end paradigm for automated biomedical discovery, ensuring mathematical boundedness and clinical relevance.